Article Information
History
- January 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jie Hu1,*,
- Pai Peng1,*,
- Kai Wang1,*,
- Bei-zhong Liu2,
- Liang Fang2,
- Fei-yang Luo3,
- Ai-shun Jin3,#,
- Ni Tang1,# and
- Ai-long Huang1,#
- 1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
- 2Yong-Chuan Hospital, Chongqing Medical University, Chongqing, China
- 3Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China
- ↵#Correspondence:
Ai-long Huang (ahuang{at}cqmu.edu.cn) or Ni Tang (nitang{at}cqmu.edu.cn) or Ai-shun Jin (aishunjin{at}cqmu.edu.cn)
↵* These authors contributed equally to this work
Posted January 22, 2021.
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
